Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study
Chisato Narita(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Keiji Yasue(Higashi Nagoya National Hospital), Wataru Fukuokaya(Jikei University School of Medicine), Jun Miki(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Steffi Kar Kei Yuen(Chinese University of Hong Kong), Shunsuke Tsuzuki(Jikei University School of Medicine), Yuta Yamada(Yamagata University), Jeremy Yuen‐Chun Teoh(Chinese University of Hong Kong), Yu Imai(Jikei University School of Medicine), Akira Furuta(Jikei University School of Medicine), Koichi Aikawa(Jikei University School of Medicine), Hiroki Yamada(Keio University), Tatsuya Shimomura(Jikei University School of Medicine), Shoji Kimura(Jikei University School of Medicine)
Cited by 2
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective
|Nature Reviews Urology|2022|196
Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis
|World Journal of Urology|2019|134
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129